Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 241-252 of 650 results.
"During the 2024 IV fluid shortage, fewer patients received fluids at lower volumes per patient. This held true for discharged patients with GI symptoms. Overall, LOS decreased without an increase in 72-h return rate. Improved throughput without changes in return rate represents a potential process improvement and warrants further evaluation" Stenson et al (2025).
"This aim of this review is to update current evidence on antibiotic stability in elastomeric infusion pumps, analyzing environmental factors, clinical efficacy, and practical challenges associated with OPAT implementation" Moreal et al (2025).
"This study demonstrates the efficacy and safety of our minimally invasive endovascular approach for managing subclavian artery catheter misplacements" Lenhart et al (2025).
"Central line-associated bloodstream infections (CLABSI) are preventable hospital-acquired infections. Predicting CLABSI helps improve early intervention strategies and enhance patient safety" Albu et al (2025).
"In this cohort study of 371 061 PIVCs, dwell time was associated with the development of BSIs with PIVCs. After day 3, PIVC indication should be reviewed and PIVC replacement considered" Zanella et al (2025).
"To improve outcomes, nurses should adhere to evidence-based protocols for maintaining IV patency and proactively educate mothers on recognizing signs of phlebitis" Casman et al (2025).
"The heparin-vancomycin-amikacin combination lock solution was more effective in preventing CRIs than heparin alone in haemodialysis patients” Arabzadeh et al (2025).
"Length of stay increased by an average of 5.2 days for falls, 12.9 days for pressure ulcers, 22.1 days for central line-associated bloodstream infections, and 7.9 days for surgical site infections” Hasan et al (2025).
"Evidence on the safety and cost-effectiveness of IV anti-cancer therapy at home is scarce and outdated. IV anti-cancer regimens have evolved; the findings of studies performed more than a decade ago may lack applicability to current practice. However, key considerations when considering suitability for home treatment remain unchanged: safety, duration of treatment and geographic catchment area” Grobler et al (2025).
"Nursing staff from a healthcare company in Rome, Italy, participated in a 25-h Field Training Course, focusing on vascular access management, promoting collaborative learning, reflection and research. Participants filled in the Nurses' knowledge and self-efficacy on vascular access devices questionnaire pre and post-course” Lommi et al (2025).
"This case report discusses a patient who presented with symptoms of a misplaced dialysis catheter and developed a life-threatening tension haemopneumothorax during its removal, in association with prior haemothorax” Patel et al (2025).
"To investigate the risk factors for complications in breast cancer patients with totally implantable access ports (TIAPs)” Fan et al (2025).
